APO-PROCHLORPERAZINE prochlorperazine maleate 5 mg tablet blister pack Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

apo-prochlorperazine prochlorperazine maleate 5 mg tablet blister pack

arrotex pharmaceuticals pty ltd - prochlorperazine maleate, quantity: 5 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; purified water; colloidal anhydrous silica; magnesium stearate - nausea and vomiting due to various causes including migraine; vertigo due to meniere's syndrome, labyrinthitis and other causes.

PROCALM prochlorperazine maleate 5 mg tablet blister pack Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

procalm prochlorperazine maleate 5 mg tablet blister pack

arrotex pharmaceuticals pty ltd - prochlorperazine maleate, quantity: 5 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; purified water; colloidal anhydrous silica; magnesium stearate - nausea and vomiting due to various causes including migraine; vertigo due to meniere's syndrome, labyrinthitis and other causes.

NAUSETIL prochlorperazine maleate 5mg tablet blister pack Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

nausetil prochlorperazine maleate 5mg tablet blister pack

aspen pharmacare australia pty ltd - prochlorperazine maleate, quantity: 5 mg - tablet, uncoated - excipient ingredients: magnesium stearate; quinoline yellow; calcium hydrogen phosphate; wheat starch; sodium lauryl sulfate - for the treatment of nausea associated with migraine.

PROCHLORPERAZINE MALEATE tablet, film coated Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

prochlorperazine maleate tablet, film coated

bionpharma inc. - prochlorperazine maleate (unii: i1t8o1jtl6) (prochlorperazine - unii:yhp6ylt61t) - for control of severe nausea and vomiting. for the treatment of schizophrenia. prochlorperazine maleate tablets are effective for the short-term treatment of generalized non-psychotic anxiety. however, prochlorperazine maleate tablets are not the first drug to be used in therapy for most patients with non-psychotic anxiety, because certain risks associated with its use are not shared by common alternative treatments (e.g., benzodiazepines). when used in the treatment of non-psychotic anxiety, prochlorperazine maleate tablets should not be administered at doses of more than 20 mg per day or for longer than 12 weeks because the use of prochlorperazine maleate tablets at higher doses or for longer intervals may cause persistent tardive dyskinesia that may prove irreversible (see warnings ). the effectiveness of prochlorperazine maleate tablets as treatment for non-psychotic anxiety was established in 4-week clinical studies of outpatients with generalized anxiety disorder. this evidence does not predict that